Related Experiment Videos
Neonatal Hypoglycemia
Alecia Thompson-Branch1, Thomas Havranek1
1Division of Neonatology, Children's Hospital at Montefiore, Bronx, NY.
Pediatrics in Review
|April 2, 2017
Summary
Neonatal hypoglycemia, or low blood glucose in newborns, is common initially but usually resolves quickly. Persistent or severe cases may indicate underlying conditions, requiring careful management based on AAP and PES guidelines.
Area of Science:
- Neonatal Medicine
- Endocrinology
- Pediatrics
Background:
- Healthy neonates commonly exhibit transiently low blood glucose levels post-birth.
- This transitional hypoglycemia typically normalizes within hours.
- A smaller group of neonates may experience prolonged or severe hypoglycemia, often linked to risk factors or congenital conditions.
Purpose of the Study:
- To review transitional and pathologic hypoglycemia in neonates.
- To present a framework for understanding American Academy of Pediatrics (AAP) and Pediatric Endocrine Society (PES) guidelines.
- To highlight key similarities and differences between the AAP and PES guidelines.
Main Methods:
- Review of existing literature on neonatal hypoglycemia.
- Analysis of current guidelines from the AAP and PES.
- Comparison of diagnostic and management approaches outlined in the guidelines.
Main Results:
- Both AAP and PES guidelines recognize that transitional neonatal hypoglycemia usually resolves within 48 hours.
- Hypoglycemia persisting beyond 48 hours is considered potentially pathologic.
- A key divergence between the guidelines lies in the target blood glucose values for neonates.
Conclusions:
- Neonatal hypoglycemia requires careful monitoring and management.
- Understanding the nuances of AAP and PES guidelines is crucial for appropriate care.
- Distinguishing between transient and pathologic hypoglycemia informs treatment strategies and aims to prevent neurologic morbidity.